mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |